Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 4
2011 3
2012 2
2013 2
2014 5
2015 3
2016 6
2017 2
2018 7
2019 5
2020 5
2021 3
2022 4
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies.
García-Calderón CB, Sierro-Martínez B, García-Guerrero E, Sanoja-Flores L, Muñoz-García R, Ruiz-Maldonado V, Jimenez-Leon MR, Delgado-Serrano J, Molinos-Quintana Á, Guijarro-Albaladejo B, Carrasco-Brocal I, Lucena JM, García-Lozano JR, Blázquez-Goñi C, Reguera-Ortega JL, González-Escribano MF, Reinoso-Segura M, Briones J, Pérez-Simón JA, Caballero-Velázquez T. García-Calderón CB, et al. Among authors: caballero velazquez t. Front Immunol. 2023 Apr 14;14:1152498. doi: 10.3389/fimmu.2023.1152498. eCollection 2023. Front Immunol. 2023. PMID: 37122702 Free PMC article.
Hematological Neoplasms with Eosinophilia.
Morales-Camacho RM, Caballero-Velázquez T, Borrero JJ, Bernal R, Prats-Martín C. Morales-Camacho RM, et al. Among authors: caballero velazquez t. Cancers (Basel). 2024 Jan 12;16(2):337. doi: 10.3390/cancers16020337. Cancers (Basel). 2024. PMID: 38254826 Free PMC article. Review.
Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study.
Caballero-Velázquez T, Pérez-López O, Yeguas Bermejo A, Rodríguez Arbolí E, Colado Varela E, Sempere Talens A, Vidriales MB, Solé-Rodríguez M, Quirós Caso C, Pérez López E, Reinoso Segura M, Prats-Martín C, Montesinos P, Pérez-Simón JA. Caballero-Velázquez T, et al. Cancers (Basel). 2023 Mar 5;15(5):1609. doi: 10.3390/cancers15051609. Cancers (Basel). 2023. PMID: 36900400 Free PMC article.
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.
Rodríguez-Arbolí E, Lee CJ, Caballero-Velázquez T, Martínez C, García-Calderón C, Jiménez-León MR, Bermúdez-Rodríguez MA, López-Corral L, Triguero A, Onstad L, Horwitz ME, Sarantopoulos S, Lee SJ, Pérez-Simón JA. Rodríguez-Arbolí E, et al. Among authors: caballero velazquez t. Clin Cancer Res. 2023 Oct 13;29(20):4057-4067. doi: 10.1158/1078-0432.CCR-23-0666. Clin Cancer Res. 2023. PMID: 37698881
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Molinos-Quintana Á, Alonso-Saladrigues A, Herrero B, Caballero-Velázquez T, Galán-Gómez V, Panesso M, Torrebadell M, Delgado-Serrano J, Pérez de Soto C, Faura A, González-Martínez B, Castillo-Robleda A, Diaz-de-Heredia C, Pérez-Martínez A, Pérez-Hurtado JM, Rives S, Pérez-Simón JA. Molinos-Quintana Á, et al. Among authors: caballero velazquez t. Front Immunol. 2024 Jan 16;14:1280580. doi: 10.3389/fimmu.2023.1280580. eCollection 2023. Front Immunol. 2024. PMID: 38292483 Free PMC article.
Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1.
Mellado-Gázquez Á, Gómez-Núñez MR, Jurado-Herrera S, Prats-Martín C, Caballero-Velázquez T, Morales-Camacho RM. Mellado-Gázquez Á, et al. Among authors: caballero velazquez t. Ann Hematol. 2022 Jun;101(6):1375-1377. doi: 10.1007/s00277-021-04742-2. Epub 2022 Jan 27. Ann Hematol. 2022. PMID: 35083526 No abstract available.
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib.
Rodríguez-Gil A, Escamilla-Gómez V, Nufer M, Andújar-Sánchez F, Lopes-Ramos T, Bejarano-García JA, García-Guerrero E, Calderón-Cabrera C, Caballero-Velázquez T, García-Calderón CB, Hernández-Díaz P, Reguera-Ortega JL, Rodríguez-Torres N, Martínez-Cibrián N, Rodríguez-Barbosa JI, Villadiego J, Pérez-Simón JA. Rodríguez-Gil A, et al. Among authors: caballero velazquez t. Sci Rep. 2022 May 19;12(1):8348. doi: 10.1038/s41598-022-12407-x. Sci Rep. 2022. PMID: 35589917 Free PMC article.
The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia.
Chulián S, Stolz BJ, Martínez-Rubio Á, Blázquez Goñi C, Rodríguez Gutiérrez JF, Caballero Velázquez T, Molinos Quintana Á, Ramírez Orellana M, Castillo Robleda A, Fuster Soler JL, Minguela Puras A, Martínez Sánchez MV, Rosa M, Pérez-García VM, Byrne HM. Chulián S, et al. Among authors: caballero velazquez t. PLoS Comput Biol. 2023 Aug 14;19(8):e1011329. doi: 10.1371/journal.pcbi.1011329. eCollection 2023 Aug. PLoS Comput Biol. 2023. PMID: 37578973 Free PMC article.
Limbus damage in ocular graft-versus-host disease.
Pérez RL, Pérez-Simón JA, Caballero-Velazquez T, Flores T, Carrancio S, Herrero C, Blanco B, Gutierrez-Cosio S, Cañete-Campos C, Cruz González F, San-Miguel JF, Hernández-Galilea E, Sánchez-Abarca I. Pérez RL, et al. Among authors: caballero velazquez t. Biol Blood Marrow Transplant. 2011 Feb;17(2):270-3. doi: 10.1016/j.bbmt.2010.08.008. Epub 2010 Aug 26. Biol Blood Marrow Transplant. 2011. PMID: 20800691 Free article.
52 results